Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NSOX triplet chemotherapy for gastric cancer with peritoneal metastasis
jRCTs051180012Phase 2Completed
- Start
- May 2018
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of paclitaxel, tegafur and oxaliplatin in gastric cancer (GC) and peritoneal carcinomatosis (PC). Started May 2018; status: completed.
02
Drugs
paclitaxeltegafuroxaliplatin
03
Conditions
gastric cancer (GC)peritoneal carcinomatosis (PC)
Beyond the preview
Go deeper on jRCTs051180012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051180012.